Greece: Only one in five new medicines reaches patients – the 'legacy' of the bailouts
Greeks wait almost two years for access to new treatments, while pharmaceutical companies increasingly say they do not intend to launch new products in the country.
Greeks wait almost two years for access to new treatments, while pharmaceutical companies increasingly say they do not intend to launch new products in the country.
What's Your Reaction?
